HW
LXRX icon

Hancock Whitney’s Lexicon Pharmaceuticals LXRX Stock Holding History

Hancock Whitney’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-245,434
Closed -$479K – 837
2020
Q1 		$479K Buy
+245,434
New +$731K 0.02% 518
2016
Q3 		– Sell
-664,025
Closed -$9.53M – 578
2016
Q2 		$9.53M Buy
664,025
+2,280
+0.3% +$30.9K 0.4% 116
2016
Q1 		$7.91K Buy
661,745
+14,350
+2% +$150K 0.33% 136
2015
Q4 		$8.62M Buy
+647,395
New +$7.96M 0.36% 120

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return